Condition

COVID-19

Treatments and trials tagged COVID-19, with the same country and access zoom as New Developments.

All New Developments

COVID-19 breakthroughs

All countriesUnited StatesCanadaUnited KingdomJapanChinaAustraliaSwitzerlandEuropean UnionNewestPatient Stories
FDA ApprovedUnited StatesJapan

New Oral Medicine to Help Prevent COVID-19 After Exposure

Xocova / Zokovea (ensitrelvir) — oral COVID-19 post-exposure prophylaxis

The first FDA-labelled oral option for COVID-19 post-exposure prophylaxis (PEP). On 29 May 2026 the FDA approved Xocova (ensitrelvir) tablets…

The first FDA-labelled oral option for COVID-19 post-exposure prophylaxis (PEP). On 29 May 2026…